Skip to content

Clinical trials

Completed Bone Diseases, Metabolic trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases, Metabolic Status: Completed Country / region: Brazil Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20101
20112
20125
20181
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Radius Health, Inc.2
Centro de Diabetes Curitiba Ltda1
Eli Lilly and Company1
Novartis Pharmaceuticals1
Pontificia Universidade Católica do Rio Grande do Sul1
Universidade Federal de Alfenas1
University of Campinas, Brazil1
University of Sao Paulo1
University of Sao Paulo General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases, Metabolic12
Osteoporosis7
Osteoporosis, Postmenopausal6
Bone Diseases2
Fractures, Bone2
Musculoskeletal Diseases2
Breast Neoplasms1
Cardiovascular Diseases1
Diabetes Mellitus1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.